GlassScriptPhysician profile
Christopher M Gentile
NPI 1730534967
$4,781.34
in general payments reported to CMS, 2019-2025
16 companies · $954 in 2025
The $954 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $822 · 2022: $1,954 · 2023: $155 · 2024: $896 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,233.01 | 2022-2025 | Xpress Loprofile, Hemopore, Scopis Ent |
| Medtronic, INC. | $884.52 | 2021-2025 | Stealthstation S8 Platform, Sinuva |
| Aerin Medical INC. | $753.95 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $491.07 | 2021-2025 | Dupixent |
| Genzyme Corporation | $347.10 | 2021-2025 | |
| Smith+Nephew, INC. | $298.37 | 2021 | |
| Inspire Medical Systems, INC. | $164.71 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $148.02 | 2022-2024 | Nucala |
| Optinose US, INC. | $147.13 | 2021-2025 | |
| Depuy Synthes Sales INC. | $128.81 | 2021 | |
| Lilly USA, LLC | $101.66 | 2025 | Zepbound |
| Acera Surgical, INC. | $18.98 | 2025 | Restrata Wound Matrix |
| Acclarent, INC | $17.39 | 2021 | |
| Hikma Pharmaceuticals USA | $16.55 | 2024 | Ryaltris |
| Paratek Pharmaceuticals, INC. | $15.43 | 2025 | Xhance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $14.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gentile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.